Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Johnson & Johnson (JNJ) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)
02:42pm, Wednesday, 03'rd Sep 2025
Johnson & Johnson (NYSE:JNJ ) 2025 Wells Fargo Healthcare Conference September 3, 2025 11:50 AM EDT Company Participants Tim Schmid - Executive VP & Worldwide Chairman of MedTech Conference Call Parti
Global drugmakers rush to boost US presence as tariff threat looms
02:09pm, Wednesday, 03'rd Sep 2025
Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the country.
J&J Gears Up for Some Key New Drug Approvals and Launches
11:06am, Wednesday, 03'rd Sep 2025
JNJ believes 10 of its new products and pipeline candidates can deliver peak sales of $5 billion, including Talvey, Tecvayli, Imaavy, Caplyta and others.
VARIPURE demonstrated strong safety outcomes with no incidence of stroke and 99.7% acute effectiveness of the VARIPULSE ™ Platform in nearly 800 enrolled patientsi IRVINE, Calif. , Sept. 2, 2025 /PR
These 4 Dividend Stocks Are Money-Printing Machines
02:10pm, Sunday, 31'st Aug 2025
Some companies excel at generating cash. They operate mature businesses that produce significantly more profit than they need to support their continued expansion.
MADRID , Aug. 31, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Late breaking clinical science data, presented at the European Society of Cardiology (ESC) Congress today and simultaneously p
J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
12:16pm, Friday, 29'th Aug 2025
JNJ halts Imaavy's rheumatoid arthritis program after trial results showed no added benefit over existing therapy.
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Friday, 29'th Aug 2025
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
J&J drops development of combination arthritis drug
05:13pm, Thursday, 28'th Aug 2025
Johnson & Johnson said on Thursday it has decided not to proceed with the development of its combination drug in patients with a type of arthritis, after results from a mid-stage trial did not show su
WASHINGTON--(BUSINESS WIRE)--The Association of Medical Device Reprocessors (AMDR) announced that Judge James Selna of the U.S. District Court for the Central District of California has issued a perma
2 High-Conviction Picks For 7.73% Growth And 4.22% Yield Within A Dividend Portfolio
03:00pm, Tuesday, 26'th Aug 2025
Through our latest additions of Deutsche Post and Meta Platforms to The Dividend Income Accelerator Portfolio, we have increased the portfolio's sector diversification and global exposure. In addition
J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?
09:41am, Monday, 25'th Aug 2025
Johnson & Johnson stock surges above key moving averages as strong results, raised guidance and growth prospects fuel momentum.
5 Blue-Chip Stocks to Buy as the Dow Achieves New Milestones
08:45am, Monday, 25'th Aug 2025
JPM, GS, JNJ, DIS, and MSFT are five blue-chip stocks that stand out with strong growth drivers and upgraded estimates as the Dow hits record highs.
JNJ Stock Surge Signals Confidence in New Growth Path
07:27am, Monday, 25'th Aug 2025
Johnson & Johnson's NYSE: JNJ stock chart is sending a clear signal that contrasts sharply with the persistent hum of repetitive negative headlines. While news cycles continue to circle long-running l
Got $500? 3 Dividend Stocks to Buy and Hold Forever
04:04am, Monday, 25'th Aug 2025
Dividend investing can be tricky, since income-focused investors want to find high yields while also avoiding stocks that end up cutting their quarterly payouts. There's a balance that has to be found
